| Literature DB >> 27800145 |
Mahya Pourostadi1, Jalil Rashedi2, Behroz Mahdavi Poor3, Hossein Samadi Kafil4, Samaneh Shirazi5, Mohammad Asgharzadeh6.
Abstract
BACKGROUND: Years after the development of antituberculosis (TB) drugs, many people continue to suffer from this disease. To control the spread of TB, strains of the Mycobacterium tuberculosis complex need to be determined, and sources of infection must be identified. Such steps should help to prevent transmission of the infection.Entities:
Keywords: ETR; Iran; Molecular Diversity; Tuberculosis
Year: 2016 PMID: 27800145 PMCID: PMC5086081 DOI: 10.5812/jjm.35520
Source DB: PubMed Journal: Jundishapur J Microbiol ISSN: 2008-3645 Impact factor: 0.747
Discriminatory Power of MIRU and ETR Typing Alone and Together[a]
| Method | Distinct Pattern | Unique Pattern | No. of Clusters | Isolates Included in Clusters | HGDI |
|---|---|---|---|---|---|
|
| 138 | 108 | 30 | 86 | 0.9930 |
|
| 55 | 30 | 25 | 164 | 0.9322 |
|
| 162 | 139 | 23 | 55 | 0.9978 |
aA score of 1 on the HGDR denoted the highest discriminatory power.
MIRU-ETR Clusters of Isolates
| MIRU-ETR Pattern[ | No. of Isolates in the Cluster |
|---|---|
|
| 6 |
|
| 4 |
|
| 3 |
|
| 3 |
|
| 3 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
aOrder of MIRU and ETR loci 2, 4, 10, 16, 20, 23, 24, 26, 27, 31, 39, 40, A, B, and C.
Allelic Diversity of Each MIRU and ETR Locus
| Locus | Number of Isolates with the Specified MIRU and ETR Copy Number | Allelic Diversity (h) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||
|
| 1 | 11 | 177 | 5 | 0.16 | ||||||
|
| 4 | 41 | 145 | 4 | 0.39 | ||||||
|
| 1 | 40 | 96 | 32 | 11 | 7 | 4 | 2 | 1 | 0.68 | |
|
| 16 | 47 | 118 | 12 | 11 | 0.56 | |||||
|
| 53 | 139 | 2 | 1 | 0.41 | ||||||
|
| 1 | 1 | 2 | 37 | 5 | 127 | 19 | 1 | 1 | 0.51 | |
|
| 61 | 131 | 2 | 0.44 | |||||||
|
| 8 | 27 | 21 | 53 | 75 | 8 | 2 | 0.74 | |||
|
| 6 | 40 | 146 | 2 | 0.39 | ||||||
|
| 17 | 158 | 18 | 1 | 0.32 | ||||||
|
| 9 | 183 | 2 | 0.10 | |||||||
|
| 5 | 67 | 81 | 32 | 7 | 2 | 0.67 | ||||
|
| 1 | 1 | 41 | 88 | 59 | 4 | 1 | 0.65 | |||
|
| 54 | 128 | 2 | 5 | 5 | 0.48 | |||||
|
| 22 | 15 | 124 | 23 | 8 | 2 | 0.55 | ||||
Risk Factors for Clustering in Northwestern Iran
| Risk Factor | No. (%) of Patients | No. (%) of Clustered Patients | No. (%) of Non Clustered Patients | P Value |
|---|---|---|---|---|
|
| 0.825 | |||
| ≤ 40 | 55 (28.35) | 14 (25.45) | 41 (29.50) | |
| 41 - 59 | 60 (30.93) | 17 (30.91) | 43 (30.93) | |
| ≥ 60 | 79 (40.72) | 24 (43.64) | 55 (39.57) | |
|
| 0.945 | |||
| Male | 98 (50.51) | 28 (50.9) | 70 (50.36) | |
| Female | 96 (49.49) | 27 (49.1) | 69 (49.64) | |
|
| 0.454 | |||
| Pulmonary | 171 (88.14) | 50 (90.9) | 121 (87.05) | |
| Extrapulmonary | 23 (11.86) | 5 (9.1) | 18 (12.95) | |
|
| 16 (8.25) | 0 (0) | 16 (11.51) | 0.007 |
|
| 78 (40.21) | 30 (54.55) | 48 (34.53) | 0.01 |
|
| 34 (17.53) | 11 (20) | 23 (16.55) | 0.569 |
|
| 64 (32.99) | 19 (34.55) | 45 (32.37) | 0.772 |
|
| 33 (17.01) | 11 (20) | 22 (15.83) | 0.486 |
|
| 26 (13.40) | 9 (16.36) | 17 (12.23) | 0.446 |
|
| 7 (3.61) | 3 (5.46) | 4 (2.88) | 0.407 |
|
| 6 (3.09) | 2 (3.64) | 4 (2.88) | >0.999 |